Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • Methods for therapeutic trials in COPD: lessons from the TORCH trial

    European Respiratory Journal Date published:

  • Improving general practice consultations for older people with asthma: a cluster randomised control trial

    Medical Journal of Australia Date published:

  • Spirometry performance in primary care: the problem, and possible solutions

    Primary Care Respiratory Journal Date published:

  • Adherence to inhaled therapy, mortality and hospital admission in COPD

    Thorax Date published:

  • Asthma in older adults: a holistic, person-centred and problem-oriented approach

    Medical Journal of Australia Date published:

  • Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents

    Medical Journal of Australia Date published:

  • Improving general practice consultations for older people with asthma: a cluster randomised control trial

    Medical Journal of Australia Date published:

  • Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

    Respiratory Research Date published:

  • Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results

    European Respiratory Journal Date published:

  • Asthma in Indigenous Australians: so much yet to do for Indigenous lung health

    Medical Journal of Australia Date published:

  • Quality of life, stage severity and COPD

    European Respiratory Journal Date published:

  • Gender Differences in Mortality of Patients with COPD: Results from the TORCH Study.

    B15. COPD PHARMACOTHERAPY Date published:

  • Evaluation of Asthma Education and Communication Skills Workshops for General Practitioners.

    C103. EDUCATING PROVIDERS AND ASSESSING QUALITY OF CARE IN PULMONARY, CRITICAL CARE, AND SLEEP MEDICINE Date published:

  • Salmeterol/Fluticasone Propionate (SFC) Is Efficacious in GOLD Stage II COPD Patients: Analysis from the TORCH Study.

    D102. CHRONIC OBSTRUCTIVE PULMONARY DISEASE PHARMACOTHERAPY Date published:

  • Lung function decline in COPD trials: Table 1-

    European Respiratory Journal Date published:

  • Benefits of fixed-dose combination therapy with inhaled corticosteroids and long-acting bronchodilators as initial maintenance therapy in the management of asthma

    Respirology Date published: